Table 3.

Factors associated with aGVHD in multivariate analysis

VariableRelative risk (95% CI)P
Patient sex   
 Male 1.00  
 Female 1.64  (1.12-2.41) .010  
Patient age   
 42 y or less 1.00  
 More than 42 y 1.70  (1.55-2.51) .007  
CD34+ cells, × 106/kg   
 (1) 2 or less 1.00 Poveralla = .021 
 (2) More than 2 to 4 2.02  (0.98-4.20) P12 = .058  
 (3) More than 4 2.62  (1.30-5.28) P13 = .007  
CD3+ cells, × 106/kg   
 (1) 0.05 or less 1.00 Poveralla = .022 
 (2) More than 0.05 to 0.1 2.06  (1.01-4.18) P12 = .045  
 (3) More than 0.1 2.45  (1.29-4.62) P13 = .006 
VariableRelative risk (95% CI)P
Patient sex   
 Male 1.00  
 Female 1.64  (1.12-2.41) .010  
Patient age   
 42 y or less 1.00  
 More than 42 y 1.70  (1.55-2.51) .007  
CD34+ cells, × 106/kg   
 (1) 2 or less 1.00 Poveralla = .021 
 (2) More than 2 to 4 2.02  (0.98-4.20) P12 = .058  
 (3) More than 4 2.62  (1.30-5.28) P13 = .007  
CD3+ cells, × 106/kg   
 (1) 0.05 or less 1.00 Poveralla = .022 
 (2) More than 0.05 to 0.1 2.06  (1.01-4.18) P12 = .045  
 (3) More than 0.1 2.45  (1.29-4.62) P13 = .006 
F3-a

indicates 2 degrees of freedom;P12, probability of testing (1) = (2); andP13, probability of testing (1) = (3).

Close Modal

or Create an Account

Close Modal
Close Modal